Work

GOG 186H: A randomized phase II evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin) in the treatment of recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer

Year: 2016

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2016.04.042

Authors: D.E. Cohn, M. Sill, J.L. Walker, D.M. O'Malley, C.I. Nagel, T. Rutledge, W.H. Bradley, D.L. Richardson, K. Moxley, C. Aghajanian

Institutions: The Ohio State University, University of Oklahoma, The University of Texas Southwestern Medical Center, University of New Mexico, Medical College of Wisconsin, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2470089902

FWCI: 0.751

Cites:

Cited by: 2

Related to: 10